Diabetes, Vol 40, Issue 1 73-81, Copyright © 1991 by American Diabetes Association

ARTICLES

Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients

PC Butler and RA Rizza
Department of Endocrinology and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

Excessive amounts of glucose enter the systemic circulation when patients with non-insulin-dependent diabetes mellitus (NIDDM) eat a carbohydrate-containing meal. To determine the contribution of hepatic glucose cycling (defined as the net effect of glucose/glucose-6-phosphate cycling and uptake and release of glucose from hepatic glycogen) to postprandial hyperglycemia, diabetic, glucose-intolerant, and nondiabetic subjects were fed mixed meals. The meal contained both [2-3H]glucose (an isotope that is extensively detritiated during hepatic glucose cycling) and [6-3H]glucose (an isotope that is not detritiated during hepatic glucose cycling). Of the 50 g of carbohydrate contained in the meal, approximately 4-8 g underwent hepatic glucose cycling. Although total cycling of ingested glucose did not differ between diabetic, glucose-intolerant, and nondiabetic subjects (361 +/- 67 vs. 494 +/- 106 vs. 322 +/- 44 mumol.kg-1.5 h-1, respectively), the data suggested that hepatic cycling was increased in the diabetic and glucose-intolerant individuals but not in the nondiabetic subjects during the first 2 h after eating. Hepatic cycling during the first 2 h after eating was correlated with the prevailing glucagon concentration (r = 0.6, P less than 0.01) and increased (P less than 0.05) as hepatic glucose release increased. Hepatic glucose cycling had a marked effect on the measurement of so-called initial splanchnic glucose uptake. Nevertheless, however measured, initial splanchnic glucose uptake was not decreased and, if anything, was increased in diabetic and glucose-intolerant patients. Integrated postprandial hepatic glucose release increased (r less than 0.01) with the severity of fasting hyperglycemia.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. E. Dunning and J. E. Gerich The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications Endocr. Rev., May 1, 2007; 28(3): 253 - 283. [Abstract] [Full Text] [PDF]

				J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]

				N. M. Doliba, W. Qin, M. Z. Vatamaniuk, C. W. Buettger, H. W. Collins, M. A Magnuson, K. H. Kaestner, D. F. Wilson, R. D. Carr, and F. M. Matschinsky Cholinergic regulation of fuel-induced hormone secretion and respiration of SUR1-/- mouse islets Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E525 - E535. [Abstract] [Full Text] [PDF]

				A. V. Matveyenko, J. D. Veldhuis, and P. C. Butler Mechanisms of impaired fasting glucose and glucose intolerance induced by a ~50% pancreatectomy. Diabetes, August 1, 2006; 55(8): 2347 - 2356. [Abstract] [Full Text] [PDF]

				A. V. Matveyenko and P. C. Butler {beta}-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes. Diabetes, July 1, 2006; 55(7): 2106 - 2114. [Abstract] [Full Text] [PDF]

				V. Rigalleau, M.-C. Beauvieux, J.-L. Gallis, H. Gin, P. Schneiter, and L. Tappy Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1198 - E1204. [Abstract] [Full Text] [PDF]

				M. C. Riddle and D. J. Drucker Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1 Diabetes Care, February 1, 2006; 29(2): 435 - 449. [Full Text] [PDF]

				H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E67 - E77. [Abstract] [Full Text] [PDF]

				M. F. Nielsen, A. Caumo, N. K. Aagaard, V. Chandramouli, W. C. Schumann, B. R. Landau, O. Schmitz, and H. Vilstrup Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1135 - G1143. [Abstract] [Full Text] [PDF]

				C. Meyer, H. J. Woerle, J. M. Dostou, S. L. Welle, and J. E. Gerich Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1049 - E1056. [Abstract] [Full Text] [PDF]

				J. Gromada, X. Ma, M. Hoy, K. Bokvist, A. Salehi, P.-O. Berggren, and P. Rorsman ATP-Sensitive K+ Channel-Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR1-/- Mouse {alpha}-Cells Diabetes, December 1, 2004; 53(suppl_3): S181 - S189. [Abstract] [Full Text] [PDF]

				K. B. Degn, C. B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B. R. Landau, and O. Schmitz One Week's Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and {alpha}- and {beta}-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes Diabetes, May 1, 2004; 53(5): 1187 - 1194. [Abstract] [Full Text] [PDF]

				G. Jiang and B. B. Zhang Glucagon and regulation of glucose metabolism Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E671 - E678. [Abstract] [Full Text] [PDF]

				H. J. Woerle, C. Meyer, J. M. Dostou, N. R. Gosmanov, N. Islam, E. Popa, S. D. Wittlin, S. L. Welle, and J. E. Gerich Pathways for glucose disposal after meal ingestion in humans Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E716 - E725. [Abstract] [Full Text] [PDF]

				P. Georg, A. Kautzky-Willer, K. Mahdjoobian, A. Hofer, R. Prager, G. Pacini, and B. H. Ludvik Influence of Metabolic Control on Splanchnic Glucose Uptake, Insulin Sensitivity, and the Time Required for Glucose Absorption in Patients With Type 1 Diabetes Diabetes Care, November 1, 2002; 25(11): 2042 - 2047. [Abstract] [Full Text] [PDF]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, W. F. Schwenk, and R. A. Rizza Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E259 - E266. [Abstract] [Full Text] [PDF]

				L. L. Kjems, B. M. Kirby, E. M. Welsh, J. D. Veldhuis, M. Straume, S. S. McIntyre, D. Yang, P. Lefebvre, and P. C. Butler Decrease in {beta}-Cell Mass Leads to Impaired Pulsatile Insulin Secretion, Reduced Postprandial Hepatic Insulin Clearance, and Relative Hyperglucagonemia in the Minipig Diabetes, September 1, 2001; 50(9): 2001 - 2012. [Abstract] [Full Text] [PDF]

				V. Rigalleau, C. Binnert, K. Minehira, N. Stefanoni, P. Schneiter, E. Henchoz, O. Matzinger, C. Cayeux, E. Jéquier, and L. Tappy In Normal Men, Free Fatty Acids Reduce Peripheral but Not Splanchnic Glucose Uptake Diabetes, April 1, 2001; 50(4): 727 - 732. [Abstract] [Full Text]

				M. Shiota, C. Postic, Y. Fujimoto, T. L. Jetton, K. Dixon, D. Pan, J. Grimsby, J. F. Grippo, M. A. Magnuson, and A. D. Cherrington Glucokinase Gene Locus Transgenic Mice Are Resistant to the Development of Obesity-Induced Type 2 Diabetes Diabetes, March 1, 2001; 50(3): 622 - 629. [Abstract] [Full Text]

				P. Shah, A. Vella, A. Basu, R. Basu, W. F. Schwenk, and R. A. Rizza Lack of Suppression of Glucagon Contributes to Postprandial Hyperglycemia in Subjects with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4053 - 4059. [Abstract] [Full Text]

				A. Caumo, R. N. Bergman, and C. Cobelli Insulin Sensitivity from Meal Tolerance Tests in Normal Subjects: A Minimal Model Index J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4396 - 4402. [Abstract] [Full Text]

				P. Shah, A. Basu, R. Basu, and R. Rizza Impact of lack of suppression of glucagon on glucose tolerance in humans Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E283 - E290. [Abstract] [Full Text] [PDF]